articleLeukemiaJul 31, 2015BRONZE OA

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

RZRobert ZeiserABAndreas BurchertCLClaudia LengerkeMVMareike VerbeekKMKristina Maas‐Bauer

University Medical Center Freiburg · Universitätsklinikum Gießen und Marburg · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

539
total citations
FWCI
33.74
Percentile
100%
References
54
Citations per year

Authors

53

Topics & keywords

Topics
Keywords
  • Ruxolitinib
  • Medicine
  • Cytopenia
  • Internal medicine
  • Hematopoietic stem cell transplantation
  • Graft-versus-host disease
  • Gastroenterology
  • Salvage therapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.